Adverse events of blood-pressure-lowering drugs: Evidence of high incidence in a clinical setting

European Journal of Clinical Pharmacology

Volumn 63, Issue 10, 2007, Pages 973-978

  Gonçalves, Carla B C ^a,b   Moreira, Leila B ^b,c   Gus, Miguel ^b,c   Fuchs, Flávio D ^b,c  

^a UNIVERSITY OF PASSO FUNDO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Adverse events; Drug therapy; Hypertension

Indexed keywords

AMILORIDE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; METOPROLOL; NIFEDIPINE; NITRENDIPINE; PROPRANOLOL; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DIZZINESS; DYSPNEA; EPIGASTRIC PAIN; FATIGUE; FEMALE; FLUSHING; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; INCIDENCE; INSOMNIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MUSCLE CRAMP; MYALGIA; NOCTURIA; OUTPATIENT; OUTPATIENT DEPARTMENT; POLYURIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; SYSTOLIC BLOOD PRESSURE; TREMOR; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

AGED; AMBULATORY CARE FACILITIES; ANTIHYPERTENSIVE AGENTS; DRUG THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548556036     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0352-y     Document Type: Article

References (33)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright, JT Jr, Roccella EJ (2003) The Seventh Report of Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560-2582
2. Fuchs FD, Gus M, Moreira WD, Moreira LB, Moraes RS, Rosito GA, Sorucco A, Atanazio P, Machado R (1997) Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort. J Hypertens 15:783-992
3. Cohen JS (2001) Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physician's Desk Reference. Arch Intern Med 161:880-885
4. Jokisalo E, Kumpusalo E, Enlund H, Takala J (2001) Patient's perceived problems with hypertension and attitudes towards medical treatment. J Hum Hypertens 15:755-761
5. World Health Organization (WHO). National Centres participating in the WHO International Drug Monitoring Programme. 1991. http://www.who-umc.org/ DynPage.aspx?id=22676 (Cited March, 2006)
6. Papademetriou V, Prisant M, Neutel JM, Weir MR (1998) Efficacy of low-dose combination of bisoprolol/hydrochlorothiazide compared with amlodipine and enalapril in men and women with essential hypertension. Am J Cardiol 81:1363-1365
7. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP (1995) Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 311:293-295
8. Ross SD, Akhras KS, Zhang SH, Rozinsky M, Nalysnyk L (2001) Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis. Pharmacotherapy 21:940-953
9. Kjellgren KI, Ahlner J, Dahlöf B, Gill H, Hedner T, Säljö R (1998) Perceived symptoms amongst hypertensive patients in routine clinical practice - a population-based study. J Intern Med 244:325-332
10. Figueiras A, Tato F, Fontaiñas JBS, Gestal-Otero JJ (1999) Influence of physician's attitudes on reporting adverse drug events: a case-control study. Med Care 37:809-814
11. Fuchs FD, Gus M, Moreira LB, Moreira WD, Gonçalves SC, Nunes G (2003) Headache is not more frequent among patients with moderate to severe hypertension. J Hum Hypertens 17:787-790
12. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure (1997) Arch Intern Med 157:2413-2446
13. Olsen H, Klemetsrud T, Stokke H, Tretli S, Westheim A (1999) Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway. Blood Press 8:94-101
14. Bardage C, Isacson D (2000) Self-reported side effects of antihypertensive drugs: An epidemiological study on prevalence and impact on health-state utility. Blood Press 9:328-334
15. Benson J, Britten N (2003) Patients' views about taking antihypertensive drugs: questionnaire study. BMJ 326:1314-1315
16. Barsky AJ, Saintfort R, Rogers MP, Bonus JF (2002) Nonspecific medication side effects and the nocebo phenomenon. JAMA 287:622-627
17. Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R, et al (1993) Treatment of Mild Hypertension Study: final results. JAMA 270:713-724
18. McMurray JJ, Östergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K (2003) CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting enzyme inhibitors: the CHARM-Added trial. Lancet 362:767-771
19. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P (2002) European Lacidipine Study on Atherosclerosis investigators Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Circulation 106:2422-2427
20. Lotufo PA, Bensenor IM (2004) Stroke mortality in São Paulo (1997-2003) - A description using the Tenth Revision of the International Classification of Diseases. Arq Neuropsiquiatr 62:1008-1011
21. Ghione S (1996) Hypertension-associated hypalgesia: evidence in experimental animals and humans, pathophysiological mechanisms, and potential clinical consequences. Hypertension 28:494-504
22. al'Absi M, Petersen KL, Wittmers LE (2000) Blood pressure but not parental history for hypertension predicts pain perception in women. Pain 88:61-68
23. Wiehe M, Fuchs SC, Moreira LB, Moraes RS, Fuchs FD (2002) Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study. J Hypertens 20:1303-1306
24. Tzourio C, Gagnière B, El Amrani M, Alpérovitch A, Bousser M-G (2003) Relationship between migraine, blood pressure and carotid thickness: a population-based study in the elderly. Cephalalgia 23:914-920
25. Hagen K, Zwart JA, Holmen J, Svebak S, Bovim G, Stovner LJ (2005) The Nord-Trondelag Health Study Does hypertension protect against chronic musculoskeletal complaints? The Nord-Trondelag Health Study. Arch Intern Med 165:916-922
26. Philipp T, Anlauf M, Distler A, Holzgreve H, Michaelis J, Wellek S (1997) Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. BMJ 315:154-159
27. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, et al (1993) A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 328:914-921
28. Law MR, Wald NJ, Morris JK, Jordan RE (2003) Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 326:1-8
29. Hanson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm JH, Syvertsen JO, Lanke J, de Faire U, Dahlof B, Karlberg BE (2000) Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardivascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 356:359-365
30. Brown MJ, Palmer CR, Castaigne A, Leew PW, Mancia G, Rosenthal T, Ruilope LM (2000) Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study (INSIGHT). Lancet 356:366-372
31. Fuchs FD (2003) Diuretics: drugs of choice for the initial management of patients with hypertension. Expert Rev Cardiovasc Ther 1:35-41
32. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, ÓBrien E, Östergren J, for the ASCOT investigators (2005) Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 366:895-906
33. Sakai H, Hayashi K, Origasa H, Kusunoki T (1999) An application of meta-analysis techniques in the evaluation of adverse experiences with antihypertensive agents. Pharmacoepidemiol Drug Saf 8:169-177